By: William Yen
Taipei, Oct. 1 (CNA) Two immunologists who were awarded the first Tang Prize in
Biopharmaceutical Science in 2014 have won the 2018 Nobel Prize in medicine for their research that has contributed to the treatment of cancer.
The Tang Prize was established by Samuel Yin (尹衍樑), a Taiwanese entrepreneur and philanthropist, in December 2012.
The duo, James Allison of the United States and Tasuku Honjo of Japan, were honored for their research into how the body’s natural defenses can fight cancer, the Tang Prize Foundation (TPF) said in a statement Monday.
Their research showed how a patient’s own immune system could be helped to fight cancer by removing a protein that can stop the body’s natural defenses from killing cancer cells, the statement said. [FULL STORY]